A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors

A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
Conditions:   Advanced or Metastatic Solid Tumors;   Ovarian Cancer;   Non-small Cell Lung Cancer;   Breast Cancer
Intervention:   Drug: NC762
Sponsor:   NextCure, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 30, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments